Mirena LNG–IUS ®
Spolehlivá a dlouhodobá antikoncepce 5 plus
Intenzita krvácení 1,2 Délka menstruace 1,2 Dysmenorea 2,3
Premenstruační syndrom 3 PID * 4
Mimoděložní těhotenství 2,4,5 + Idiopatická menoragie 5
důvěra která trvá
1. Pakarinen P., Luukkainen T. Treatment of menorrhagia with an LNG-IUS. Contraception 2007; 75:S118–S122. 2. Chi.I-C, Farr G. The non-contraceptive effct of levonorgest- rel-releasing intrauterine device. Advances in Contraception 1994; 10: 271-285. 3. Barrington J.W., Bowen-Simkins P. The levonorgestrel intrauterine system in the treatment of menorrhagia. Br. J. Obstet. Gynaecol. 1997; 104: 614-616. 4. Andersson K., Odlind V., Rybo G. Levonorgestrel-releasing and cooper-releasing (Nova-T) IUDs during fi ve years of use: A randomised comparative trial. Contraception 1994; 49: 56-72. 5. SPC Mirena, 24. 10. 2007
* Pánevní infekční onemocnění Zastoupení: Bayer Schering Pharma BAYER s.r.o., Siemensova 2717/4, 155 80 Praha 5, e-mail
info@bayerscheringpharma.cz
WH-09-09-0118-CZ
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52